Osteocalcin Expression by Circulating Endothelial Progenitor Cells in Patients With Coronary Atherosclerosis

Journal of the American College of Cardiology

Volumn 52, Issue 16, 2008, Pages 1314-1325

  Gössl, Mario ^a   Mödder, Ulrike I ^a   Atkinson, Elizabeth J ^a   Lerman, Amir ^a   Khosla, Sundeep ^a  

^a MAYO CLINIC   (United States)

Author keywords

atherosclerosis; bone; calcification

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; OSTEOCALCIN; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; BLOOD VESSEL CALCIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE MARKER; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; LOGISTIC MODELS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOCALCIN; POLYMERASE CHAIN REACTION; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; RNA, MESSENGER; ROC CURVE; SENSITIVITY AND SPECIFICITY; STEM CELLS;

EID: 53049103869     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.07.019     Document Type: Article

References (48)

1. Tanko L.B., Christiansen C., Cox C.A., Geiger M.J., McNabb M.A., and Cummings S.R. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20 (2005) 1912-1920
2. Sambrook P.N., Chen C.J.S., March L.M., et al. High bone turnover is an independent predictor of mortality in the frail elderly. J Bone Miner Res 21 (2006) 549-555
3. Bucay N., Sarosi I., Dunstan C.R., et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12 (1998) 1260-1268
4. Johnson R.C., Leopold J.A., and Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99 (2006) 1044-1059
5. Rajamannan N.M., Bonrow R.O., and Rahimtoola S.H. Calcific aortic stenosis: an update. Nat Clin Pract Cardiovasc Med 4 (2007) 254-262
6. Urbich C., and Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95 (2004) 343-353
7. + endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 98 (2006) e20-e25
8. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9 (2003) 702-712
9. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., and Frolova G.P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6 (1968) 230-247
10. Long M.W., Williams J.L., and Mann K.G. Expression of human bone-related proteins in the hematopoietic microenvironment. J Clin Invest 86 (1990) 1387-1395
11. Long M.W., Robinson J.A., Ashcraft E.A., and Mann K.G. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest 95 (1995) 881-887
12. Long M.W., Ashcraft E.K., Normalle D., and Mann K.G. Age-related phenotypic alterations in populations of purified human bone precursor cells. J Gerontol 54A (1999) B54-B62
13. Eipers P.G., Kale S., Taichman R.S., et al. Bone marrow accessory cells regulate human bone precursor cell development. Exp Hematol 28 (2000) 815-825
14. Eghbali-Fatourechi G.Z., Lamsam J., Fraser D., Nagel D.A., Riggs B.L., and Khosla S. Circulating osteoblast-lineage cells in humans. N Engl J Med 352 (2005) 1959-1966
15. Eghbali-Fatourechi G.Z., Moedder U.I., Charatcharoenwitthaya N., et al. Characterization of circulating osteoblast linage cells in humans. Bone 40 (2007) 1370-1377
16. Simmons P.J., and Torok-Storb B. Identification of stromal cell precursors in human bone marrow by novel monoclonal antibody, STRO-1. Blood 78 (1991) 55-62
17. + cells from human bone marrow. Stem Cells 15 (1997) 368-377
18. Tondreau T., Meuleman N., Delforge A., et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 23 (2005) 1105-1112
19. Matsumoto T., Kawamoto A., Kuroda R., et al. Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am J Pathol 169 (2006) 1440-1457
20. Wilson P.W.F., D'Agostino Sr. R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
21. Suwaidi J.A., Higano S.T., Hamasaki S., Holmes Jr. D.R., and Lerman A. Association between obesity and coronary atherosclerosis and vascular remodeling. Am J Cardiol 88 (2001) 1300-1303
22. Hasdai D., Gibbons R.J., Holmes Jr. D.R., Higano S.T., and Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 96 (1997) 3390-3395
23. Lerman A., and Zeiher A.M. Endothelial function: cardiac events. Circulation 111 (2005) 363-368
24. Suwaidi J.A., Hamasaki S., Higano S.T., Nishimura R.A., Holmes Jr. D.R., and Lerman A. Long-term follow-up of patients with mild artery disease and endothelial dysfunction. Circulation 101 (2000) 948-954
25. Vandesompele J., De Preter K., Pattyn F., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 (2002) Research0034
26. Radonic A., Thulke S., Mackay I.M., Landt O., Siegert W., and Nitsche A. Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 313 (2004) 856-862
27. DeLong E.R., and Delong D.M. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44 (1988) 837-845
28. Asher J., and Houston M. Statins and C-reactive protein levels. J Clin Hypertens 9 (2007) 622-628
29. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
30. Holmes Jr. D.R., Teirstein P., Satler L., et al. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents. JAMA 295 (2006) 1264-1273
31. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) e1-e7
32. Schoppet M., Sattler A.M., Schaefer J.R., Herzum M., Maisch B., and Hofbauer L.C. Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab 88 (2003) 1024-1028
33. Doherty T.M., Fitzpatrick L.A., Inoue D., et al. Molecular, endocrine, and genetic mechanisms of arterial calcification. Endocr Rev 25 (2004) 629-672
34. Deniaud A., el Dein O.S., Maillier E., et al. Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochonchondrial outer membrane permeabilization and apoptosis. Oncogene 27 (2008) 285-299
35. Liaw L., Almeida M., Hart C.E., Schwartz S.M., and Giachelli C.M. Osteopontin promotes vascular cell adhesion and spreading and is chemtactic for smooth muscle cells in vitro. Circ Res 74 (1994) 214-224
36. Gabbasov Z.A., Agapov A.A., Saburova O.S., Obedzinskii E.A., and Soboleva E.L. Detection of circulating stromal stem cells with osteogenic potential in the blood of coronary patients by laser flow cytometry. Bull Exp Biol Med 139 (2005) 266-268
37. Gabbasov Z.A., Agapov A.A., Saburova O.S., et al. Circulating stromal osteonectin-positive progenitor cells and stenotic coronary atherosclerosis. Can J Physiol Pharmacol 85 (2007) 295-300
38. Bick T., Rozen N., Dreyfuss E., Soundry M., and Lewinson D. Osteogenic differentiation of circulating endothelial progenitor cells. J Bone Miner Res 22 (2007) S143
39. Weber G.F., Ashkar S., Glimcher M.J., and Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271 (1996) 509-512
40. Ohmori R., Momiyama Y., Taniguchi H., et al. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 170 (2003) 333-337
41. Standal T., Borset M., and Sundan A. Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol 26 (2004) 179-184
42. Abedin M., Tintut Y., and Demer L.L. Mesenchymal stem cells and the artery wall. Circ Res 95 (2004) 671-676
43. Shao J.S., Cheng S.L., Pingsterhaus J.M., Charlton-Kachigian N., Loewy A.P., and Towler D.A. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 115 (2005) 1210-1220
44. Burke A.P., Kolodgie F.D., Farb A., Weber D., and Virmani R. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation 105 (2002) 297-303
45. Ward M.R., Pasterkamp G., Yeung A.C., and Borst C. Arterial remodeling. Mechanisms and clinical implications. Circulation 102 (2000) 1186-1190
46. Cranenburg E.C., Vermeer C., Koos R., et al. The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res 45 (2008) 427-436
47. Hill J.M., Zalos G., Halcox J.P.J., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
48. Gomez-Cerezo J.F., Pagan-Munoz B., Lopez-Rodriguez M., Estebanez-Munoz M., and Barbaro-Hernandez F.J. The role of endothelial progenitor cells and statins in endothelial function: a review. Cardiovasc Hematol Agents Med Chem 5 (2007) 265-272